(Q51740189)

11 April 2018

title

The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS. (English)

1 reference

11 April 2018

20

Marelize Gorgens

1 reference

11 April 2018

Janka Petravic

16

object named as

Janka Petravic

1 reference

11 April 2018

author name string

Sherrie L Kelly

1

1 reference

11 April 2018

Rowan Martin-Hughes

2

1 reference

11 April 2018

Robyn M Stuart

3

1 reference

11 April 2018

Xiao F Yap

4

1 reference

11 April 2018

David J Kedziora

5

1 reference

11 April 2018

Kelsey L Grantham

6

1 reference

11 April 2018

S Azfar Hussain

7

1 reference

11 April 2018

Iyanoosh Reporter

8

1 reference

11 April 2018

Andrew J Shattock

9

1 reference

11 April 2018

Laura Grobicki

10

1 reference

11 April 2018

Hassan Haghparast-Bidgoli

11

1 reference

11 April 2018

Jolene Skordis-Worrall

12

1 reference

11 April 2018

Zofia Baranczuk

13

1 reference

11 April 2018

Olivia Keiser

14

1 reference

11 April 2018

Janne Estill

15

1 reference

11 April 2018

Richard T Gray

17

1 reference

11 April 2018

Clemens J Benedikt

18

1 reference

11 April 2018

Nicole Fraser

19

1 reference

11 April 2018

David Wilson

21

1 reference

11 April 2018

Cliff C Kerr

22

1 reference

11 April 2018

David P Wilson

23

1 reference

11 April 2018

publication date

9 March 2018

1 reference

11 April 2018

published in

The lancet. HIV

1 reference

11 April 2018

volume

5

1 reference

11 April 2018

issue

4

1 reference

11 April 2018

page(s)

e190-e198

1 reference

11 April 2018

What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Towards an improved investment approach for an effective response to HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Optimization by Adaptive Stochastic Descent.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2818%2930024-9

7 January 2021

10.1016/S2352-3018(18)30024-9

Identifiers

DOI

1 reference

11 April 2018

PubMed ID

29540265

1 reference

11 April 2018